MCD vs MS: Which Is the Better Buy?

Side-by-side comparison of McDonald's Corporation and Morgan Stanley β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-05-09.
McDonald's Corporation Β· Consumer Cyclical
$275.75
+18.8% upside to fair value
Grade C High Quality
VS
Morgan Stanley Β· Financial Services
$189.30
+45.0% upside to fair value
Grade C High Quality
QuantHub Verdict
MS has more upside to fair value (+45.0%). MS trades at a lower forward P/E (16.4x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric MCD MS
Current Price $275.75 $189.30
Fair Value Estimate $327.62 $274.49
Upside to Fair Value +18.8% +45.0%
Market Cap $196.0B $300.6B
Forward P/E 22.6x 16.4x
EV / EBITDA 16.7x 24.4x
Price / Sales 7.1x 2.5x
Price / FCF 27.9x -16.8x
Revenue Growth YoY +9.4% +18.8%
Gross Margin 57.4% 58.0%
Operating Margin 46.0% 19.5%
Return on Equity -434.0% 16.7%
Dividend Yield 0% 0%
FCF Yield 3.59% β€”
Analyst Consensus Buy Hold
Investment Thesis
MCD β€” McDonald's Corporation
McDonald's Corporation operates a global quick-service restaurant business with a strong competitive moat driven by brand recognition, extensive franchising, and digital innovation. The company reported $26.9 billion in revenue for fiscal 2025, growing 4% year-over-year, with significant contributions from its International Operated Markets segment growing nearly 8%. Despite a high valuation regi…
MS β€” Morgan Stanley
Morgan Stanley is a leading global financial services firm operating in Institutional Securities, Wealth Management, and Investment Management. The company benefits from a durable competitive moat supported by its systemically important status, diversified revenue streams, and strong management with a 36-year veteran CEO. Despite solid fundamentals including 14.2% revenue growth in 2025 and 16.7%…
Accumulation Zones
Metric MCD MS
Zone Low $245.72 $205.87
Zone High $278.48 $233.32
In Buy Zone? Yes Yes
← MCD Research    MS Research β†’    All Research